Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ZERACRYL AS
AS
Active
Org 992019360
Kolbotnveien 7, 1410
Kolbotn
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2007 · 18 years old
0 employees
www.zeracryl.no
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ZERACRYL AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HL
Haakon Lude Sande
Chief Executive Officer
Chief Executive Officer
2025
Former (1)
TW
Thea Wencke Sundt
Chief Executive Officer
Chief Executive Officer
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ES
Erik Slinde
Chairman
Chairman
2022
AO
Andreas Odfjell
Board of Directors
Board of Directors
2022
Former (4)
MS
Mohamed Sambou
Board of Directors
Board of Directors
2022 – 2025
RO
Ragni Ofstad
Board of Directors
Board of Directors
2022 – 2025
TE
Trond Erling Thomassen
Board of Directors
Board of Directors
2022 – 2023
JE
Jan Erik Tveteraas
Board of Directors
Board of Directors
2022 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Thea Wenche Sundt Holding As
Company
21.11%
21.11%
2025
Sande Holding As
Company
18.81%
18.81%
2025
Skibs As Anod
Company
13.99%
13.99%
2025
Salei A/S
Company
8.64%
8.64%
2025
Grete Skrede
Individual
6.46%
6.46%
2025
Eikebraate Invest As
Company
3.73%
3.73%
2025
Rakkarberget As
Company
3.36%
3.36%
2025
Nofima As
Company
3.28%
3.28%
2025
Grethe Enersen
Individual
3.02%
3.02%
2025
Trothom As
Company
2.44%
2.44%
2025
Torger Baardseth
Individual
2.22%
2.22%
2025
George Harkins
Company
2.03%
2.03%
2025
Strand & Partners As
Company
1.91%
1.91%
2025
Sylvi Johanne Baardseth Panjwani
Individual
1.75%
1.75%
2025
David Halten
Individual
1.19%
1.19%
2025
Kjærlighetshjelp As
Company
1.09%
1.09%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ZERACRYL AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network